Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
Brokerages Set NeoGenomics, Inc. (NASDAQ:NEO) PT at $33.00
09:04am, Wednesday, 08'th Apr 2020
Shares of NeoGenomics, Inc. (NASDAQ:NEO) have been given an average recommendation of “Buy” by the ten analysts that are covering the company, MarketBeat reports. One analyst has rated the stock w
Should You Avoid Simmons First National Corporation (SFNC)?
09:17pm, Tuesday, 07'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Franklin Resources Inc. Trims Stake in NeoGenomics, Inc. (NASDAQ:NEO)
10:20am, Monday, 06'th Apr 2020
Franklin Resources Inc. reduced its position in NeoGenomics, Inc. (NASDAQ:NEO) by 15.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC)
Fulton Bank N.A. Sells 9,168 Shares of NeoGenomics, Inc. (NASDAQ:NEO)
09:24am, Sunday, 05'th Apr 2020
Fulton Bank N.A. lowered its position in NeoGenomics, Inc. (NASDAQ:NEO) by 46.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 10,779 shares of the medical r
Goldman Sachs Group Inc. Acquires 79,040 Shares of NeoGenomics, Inc. (NASDAQ:NEO)
09:53am, Saturday, 04'th Apr 2020
Goldman Sachs Group Inc. boosted its holdings in NeoGenomics, Inc. (NASDAQ:NEO) by 24.8% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. T
NeoGenomics Highlights Integration Of Indica Labs' HALO AP Image Analysis Platform
11:04am, Friday, 03'rd Apr 2020NeoGenomics Integrates HALO(R) From Indica Labs
11:00am, Friday, 03'rd Apr 2020
FT. MYERS, FL / ACCESSWIRE / April 3, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused testing services, today announced that it has integrated Indica Labs enterprise-level
NeoGenomics, Inc. to Post Q3 2020 Earnings of $0.09 Per Share, SVB Leerink Forecasts (NASDAQ:NEO)
07:48am, Friday, 03'rd Apr 2020
NeoGenomics, Inc. (NASDAQ:NEO) – Research analysts at SVB Leerink upped their Q3 2020 EPS estimates for shares of NeoGenomics in a research note issued to investors on Monday, March 30th. SVB Leerin
NASA Asteroid Tracker: 151-Foot NEO Currently Headed For Earth
01:22am, Friday, 03'rd Apr 2020
NASA is currently monitoring a building-sized asteroid that’s expected to approach Earth tomorrow.
Bank of America Corp DE Sells 87,482 Shares of NeoGenomics, Inc. (NASDAQ:NEO)
09:24am, Thursday, 02'nd Apr 2020
Bank of America Corp DE lessened its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 11.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Ex
NeoGenomics (NASDAQ:NEO) Trading 0.1% Higher
08:40am, Thursday, 02'nd Apr 2020
NeoGenomics, Inc. (NASDAQ:NEO)’s stock price traded up 0.1% on Tuesday . The company traded as high as $27.89 and last traded at $27.73, 34,783 shares traded hands during mid-day trading. A decline
Brokers Offer Predictions for NeoGenomics, Inc.'s Q2 2020 Earnings (NASDAQ:NEO)
06:00am, Thursday, 02'nd Apr 2020
NeoGenomics, Inc. (NASDAQ:NEO) – Research analysts at SVB Leerink cut their Q2 2020 EPS estimates for NeoGenomics in a note issued to investors on Monday, March 30th. SVB Leerink analyst P. Souda no
Bitcoin Takes Tumble, Traders Fret Correlation and Next Month’s Halving
08:31pm, Wednesday, 01'st Apr 2020
Bitcoin had another down day. How long the cryptocurrency follows stocks, and whether next month’s halving juices its price, remain open questions.
NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020
11:00am, Wednesday, 01'st Apr 2020
FT. MYERS, FL / ACCESSWIRE / April 1, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its first quarter 2
Bank of New York Mellon Corp Has $44.78 Million Stake in NeoGenomics, Inc. (NASDAQ:NEO)
10:20am, Tuesday, 31'st Mar 2020
Bank of New York Mellon Corp raised its holdings in NeoGenomics, Inc. (NASDAQ:NEO) by 2.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,530
